Hahn-Schickard produces PCR rapid tests for SARS-CoV-2

The new test system just released to the market on November 16, 2020 as an approved medical product by Sindiag GmbH is safe to operate, time-saving and designed for mobile use.

“The last few months have been very demanding on us, but with our combined efforts we did it,” Dr. Markus Rombach is pleased to report. He is in charge of the development project at Hahn-Schickard and, together with the production manager Dr. Rouven Streller, has established the disposable test cartridges at production in accordance with the specifications from the client Spindiag. Hahn-Schickard produces the cartridges for the handy “Rhonda Player” analysis device for the market launch on behalf of Spindiag on its own production line in the BioTechPark in Freiburg. “With the certification of our quality management system according to the medical device standard EN ISO 13485, we have reached another important milestone. It enables us to develop and manufacture in vitro diagnostics for clinical and point-of-care applications with the highest quality standards,” explains Professor Roland Zengerle, Hahn-Schickard Institute Director in Freiburg and Head of the Laboratory for MEMS Applications at the Department of Microsystems Engineering at the University of Freiburg.

Further information

Further information:

Spindiag Press Release

Pressemitteilung des Ministeriums für Wirtschaft, Arbeit und Wohnungsbau Baden-Württemberg (16.11.2020)


Prof. Dr. Roland Zengerle
Phone:  +49 761 203 73200
Contact via mail

Katrin Grötzinger
Phone: +49 761 203 73242
Contact via mail